EWM
ORKA

Edge Wealth Management’s Oruka Therapeutics ORKA Stock Holding History

Edge Wealth Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1
Closed -$1K – 484
2015
Q2 		$1K Hold
1
– – ﹤0.01% 418
2015
Q1 		$1K Buy
+1
New +$1.17K ﹤0.01% 432

Other funds holding ORKA

VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Edge Wealth Management's ORKA Position: Q3 2015 in Review

Edge Wealth Management sold out of Oruka Therapeutics (ORKA) in Q3 2015, closing a stake of 1 share — an estimated $1K sold.

Edge Wealth Management first reported a position in ORKA in Q1 2015 and held it in 2 quarters. The position peaked at $1K in Q2 2015. 13 funds tracked by Wall St. Rank hold ORKA as of Q3 2015.

  • Edge Wealth Management reported no remaining Oruka Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Edge Wealth Management sold 1 Oruka Therapeutics share in Q3 2015, an estimated $1K.
  • Edge Wealth Management first reported a position in Oruka Therapeutics in Q1 2015 and held it in 2 quarters.
  • Edge Wealth Management's Oruka Therapeutics position peaked at $1K in Q2 2015.
  • 13 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2015.

Based on Edge Wealth Management's 13F filing for Q3 2015, filed 7 Oct 2015.